Lincoln National (LNC) Q3 2026 Earnings Call Transcript

Lincoln National reported Q3 adjusted operating income of $339 million, or $1.72 per diluted share, including a $95 million ($0.48 per share) reduction from its annual assumption review; net income was $1.3 billion, primarily reflecting favorable changes in market risk benefits and embedded derivatives. Annuity sales rose 21% sequentially to $4.3 billion, while the company resumed buybacks with $50 million of repurchases and retired $437 million of preferred stock. Group Protection margins fell 260 basis points year over year to 5.5%, and management expects the full-year margin at or modestly below the low end of its prior 8%-9% range; Q4 Retirement Plan Services net outflows are projected at $3 billion.

Analysis

The earnings signal is less clean than the headline GAAP result: a meaningful portion of operating performance came from above-target alternatives and favorable life mortality, while disability incidence is reverting toward normal. The key underwriting test is whether pricing, mix and expense actions can replace those tailwinds; until then, extrapolating current earnings risks overvaluing LNC’s run rate.

The more durable positive is a shift toward spread-based annuities and reduced legacy guarantees. That can improve earnings visibility, but it also increases the importance of disciplined product pricing and asset-liability management. In a more aggressive fixed-annuity market, sales growth is not inherently value-accretive: weaker new-business spreads or lower reinvestment yields could turn the mix shift into a margin trap. Reinsurance reduces retained legacy exposure but makes counterparty and collateral terms worth monitoring.

Near term, the disability severity bounce is a potential Q4 relief, but incidence normalization is structural rather than a one-quarter anomaly. The February 2027 outlook is the key 1–3 month catalyst for testing whether buybacks can grow alongside business investment. The $1.3 billion net-income figure should not anchor valuation; capital strength and subsidiary remittances do not make all reported capital immediately distributable. The contrarian risk is that investors price the transformation as complete before new spread balances and the RPS realignment demonstrate durable, normalized returns.

Key Decisions for Investors

• No unconditional post-earnings chase: valuation and the market’s embedded 2027 earnings assumptions are missing. Consider a measured LNC long only if the price reaction does not capitalize temporary alternative-return and mortality benefits as recurring earnings.
• Use the February 2027 outlook as the add/reassess catalyst. Favor adding only if guidance supports sustainable underlying earnings and capital return without relying on unusually strong alternatives or continued favorable mortality.
• Monitor Group Protection disability loss ratios and full-year margin. A persistent deterioration after the severity volatility fades—or evidence incidence is worse than management’s normalized assumption—would falsify the earnings-recovery thesis.
• Track fixed-annuity new-business economics, not sales alone: verify credited rates, portfolio yields and spread contribution in filings and subsequent calls. Intensifying price competition or spread compression would undermine the intended mix improvement.
• Treat buybacks as supportive, not proof of excess capital: verify remittance generation, RBC and holding-company liquidity after preferred redemption. A materially weaker capital-return outlook or adverse reinsurance/collateral development would warrant reducing exposure.